April 22, 2025

AHA Framework Maps HF Prevention Strategy

“The growing morbidity, mortality, and health care costs related to heart failure underscore the urgent need to prioritize its primary prevention.”

Conexiant

April 16, 2025

CONSORT 2025: Setting New Standards for Clinical Trial Reporting

"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.

Conexiant

April 09, 2025

USPSTF Releases Breastfeeding Evidence Report

Interventions can increase breastfeeding up to 6 months postpartum.

Conexiant

April 01, 2025

Ocular Surface News - April 9, 2025

Intriguing research explores the surprising connection between gout and dry eye symptoms, highlighting lifestyle factors and systemic inflammation. Early detection and treatment are crucial for patient care.

Optometric Management

April 01, 2025

Clinical Trial Update April 2025

Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.

Retinal Physician

January 14, 2025

Does Screening Cut Hip Fracture Risks?

"Screening in higher-risk women 65 years or older was associated with a small absolute risk reduction in hip and major fractures compared with usual care."

Conexiant

July 29, 2024

Management of Elevated BP in Hospitalized Patients: A New Approach

A recent clinical insights article presents a new framework for managing asymptomatic elevated blood pressure in hospitalized patients, challenging current practices by emphasizing a cautious approach based on recent observational studies.

Conexiant

May 24, 2024

Senate committee holds hearing on dental affordability and availability

A Senate committee discussed various ways to make oral health care more accessible and affordable for Americans, including.

ADA News

November 13, 2024

Is COPD Set to Affect 600M Globally?

GOLD 2025 highlights new pathways and advanced COPD therapies like ensifentrine and dupilumab to reduce exacerbations and address emerging COPD phenotypes.

Conexiant